6.2.1. clinical stage (persistently) elevated serum tumour markers. elevated markers cs i, weekly measurement markers recommended. afp β-hcg increase fail normalise following orchidectomy, us examination contralateral testicle must performed. contralateral tumour excluded, unequivocal rising tumour markers indicates cs i, treatment good prognosis metastatic gct given. stable markers, new staging procedure, 4-6 weeks orchidectomy, recommended. patients may stable slightly elevated afp β-hcg initially monitored. treatment commenced markers rise follow-up imaging demonstrates metastatic disease. treatment true cs sgct metastatic gct. this, ten-year overall survival 95%, reported .